Inactive Instrument

Other languages Aethlon Medical, Inc. OTC Bulletin Board

Equities

AEMD

US00808Y1091

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Aethlon Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 14
Aethlon Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 14
Aethlon Medical, Inc Announces Executive Changes	Nov. 13
Aethlon Medical, Inc. Announces Appointment Ofguy Ciprian as Chief Operating Officer	Nov. 13
Aethlon Medical, Inc. Receives Clearance from Drug Controller General of India for Potential Phase 1 Trial of its Hemopurifier(R) in Oncology	23-10-10
Aethlon Medical Board Approves 1-for-10 Reverse Stock Split	23-10-04
Aethlon Medical, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-10
Aethlon Medical, Inc. Appoints Nicolas Gikakis as Member of the Board and Member of the Nominating Committee	23-07-06
Aethlon Medical, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	23-06-28
Aethlon Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-13
Aethlon Medical Taps Namsa to Manage Planned Clinical Trial of Medical Device for Cancer	23-01-30
Aethlon Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-14
Aethlon Medical, Inc. Announces Early Feasibility Study of the Hemopurifier	22-09-29
Aethlon Medical, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-09
Aethlon Medical Receives FDA Approval to Eliminate Dialysis Treatment as Requirement for Hemopurifier COVID-19 Study	22-07-11
Aethlon Medical, Inc. Announces U.S. FDA Approval of Hemopurifier COVID-19 Study Protocol Amendment	22-07-11
Aethlon Medical Posts Wider Loss, Lower Revenue for Full-Year Fiscal 2022	22-06-28
Aethlon Medical, Inc. Reports Earnings Results for the Full Year Ended March 31, 2022	22-06-28
Aethlon Medical Publishes In Vitro Studies Demonstrating Hemopurifier Resin Binding of Seven Clinically Relevant COVID-19 Variants	22-05-02
Aethlon Medical, Inc. Announces Executive Changes	22-03-28

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Aethlon Medical, Inc. OTC Bulletin Board

Equities

AEMD

US00808Y1091

Other languages

Filters